Atom | Partnerships for Development of Vaccines to Prevent Mycobacterium tuberculosis Infection and/or Tuberculosis (R01 Clinical Trial Not Allowed)

Funder: National Institutes of Health (NIH)

Due Dates: November 7, 2025 (anticipated)

Funding Amounts: Estimated total program funding: $4,730,000; ~5 awards expected; R01 mechanism; duration typically up to 5 years

Summary: Supports preclinical research to develop lead vaccine candidates to prevent Mycobacterium tuberculosis infection and/or tuberculosis disease.

Key Information: Forecasted opportunity; application details and NOFO to be published—plan collaborations now.

Partnerships for Development of Vaccines to Prevent Mycobacterium tuberculosis Infection and/or Tuberculosis (R01 Clinical Trial Not Allowed)

Sign in to see full grant listing